Molecular Pathology of Nervous System Tumors

作者: Catherine L. Nutt , Anat O. Stemmer-Rachamimov , J. Gregory Cairncross , David N. Louis

DOI: 10.1385/1-59259-843-9:033

关键词:

摘要: In modern clinical neuro-oncology, no variable affects therapeutic decisions and prognostic estimation more than tumor classification. The most widely used method of brain classification is that the World Health Organization (WHO), recently revised in 2000 (51), which based on microscopic examination tissue by a pathologist. WHO divides nervous system tumors into many nosological entities (Table 1) assigns grade I to IV, being benign IV highly malignant. Although, majority cases, assignment relevant appropriate, unfortunately there are situations this problematic, primarily because pathological diagnosis remains quite subjective (67). For example, some difficult place neatly one categories. others, histological corresponding predicted behavior do not concur with actual course. Finally, it doubtful current histopathological alone will accurately predict patient response targeted therapies once available. As such, information capable augmenting could result marked improvements approach

参考文章(142)
Seung-Ki Kim, Kyu-Chang Wang, Byung-Kyu Cho, Hee-Won Jung, Yun Jin Lee, Young Seob Chung, Ji-Young Lee, Se-Hyuck Park, Yoen-Mee Kim, Gheeyoung Choe, Je G. Chi, Biological behavior and tumorigenesis of subependymal giant cell astrocytomas. Journal of Neuro-oncology. ,vol. 52, pp. 217- 225 ,(2001) , 10.1023/A:1010664311717
Dan X. Cai, Ruma Banerjee, Bernd W. Scheithauer, Christine M. Lohse, Bette K. Kleinschmidt-Demasters, Arie Perry, Chromosome 1p and 14q FISH analysis in clinicopathologic subsets of meningioma: diagnostic and prognostic implications. Journal of Neuropathology and Experimental Neurology. ,vol. 60, pp. 628- 636 ,(2001) , 10.1093/JNEN/60.6.628
David N. Louis, Eric C. Holland, J. Gregory Cairncross, Glioma Classification: A Molecular Reappraisal American Journal of Pathology. ,vol. 159, pp. 779- 786 ,(2001) , 10.1016/S0002-9440(10)61750-6
Hikaru Sasaki, Magdalena C. Zlatescu, Rebecca A. Betensky, Loki B. Johnk, Andrea N. Cutone, J. Gregory Cairncross, David N. Louis, Histopathological-molecular genetic correlations in referral pathologist-diagnosed low-grade "oligodendroglioma" Journal of Neuropathology and Experimental Neurology. ,vol. 61, pp. 58- 63 ,(2002) , 10.1093/JNEN/61.1.58
Satoshi Ozaki, Takafumi Nishizaki, Haruhide Ito, Kohsuke Sasaki, Comparative genomic hybridization analysis of genetic alterations associated with malignant progression of meningioma. Journal of Neuro-oncology. ,vol. 41, pp. 167- 174 ,(1999) , 10.1023/A:1006086723607
G Reifenberger, K Ichimura, V P Collins, E E Schmidt, CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Research. ,vol. 54, pp. 6321- 6324 ,(1994)
Ralf F. Pettersson, A. Jonas Ekstrand, C. David James, V. Peter Collins, V. Peter Collins, Barbara Seliger, Webster K. Cavenee, Genes for Epidermal Growth Factor Receptor, Transforming Growth Factor α, and Epidermal Growth Factor and Their Expression in Human Gliomas in Vivo Cancer Research. ,vol. 51, pp. 2164- 2172 ,(1991)
Corey Raffel, Benjamin Alderete, Deanne Hebrink, C. David James, Robert B. Jenkins, Daniel W. Fults, Lori Frederick, Sporadic Medulloblastomas Contain PTCH Mutations Cancer Research. ,vol. 57, pp. 842- 845 ,(1997)
Sandra H.E. Sprenger, Johanna M.M. Gijtenbeek, Pieter Wesseling, Raf Sciot, Frank Van Calenbergh, Martin Lammens, Judith W. M. Jeuken, Characteristic chromosomal aberrations in sporadic cerebellar hemangioblastomas revealed by comparative genomic hybridization. Journal of Neuro-oncology. ,vol. 52, pp. 241- 247 ,(2001) , 10.1023/A:1010623119469